![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment... Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. Show more
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo® (vadadustat) Tablets PR Newswire CAMBRIDGE, Mass., July 11, 2024 Akebia regains full rights to sell...
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE, Mass., July 1, 2024 CAMBRIDGE, Mass., July 1, 2024 /PRNewswire/ -- Akebia Therapeutics®...
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire CAMBRIDGE, Mass., June 27, 2024 CAMBRIDGE, Mass., June 27, 2024 /PRNewswire/ -- Akebia...
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer PR Newswire CAMBRIDGE, Mass., June 24, 2024 CAMBRIDGE, Mass., June 24, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.18 | 19.1489361702 | 0.94 | 1.08 | 0.91 | 2198089 | 0.98223155 | CS |
4 | -0.01 | -0.884955752212 | 1.13 | 1.195 | 0.8 | 4539102 | 0.98314028 | CS |
12 | -0.25 | -18.2481751825 | 1.37 | 1.56 | 0.8 | 3198388 | 1.12187573 | CS |
26 | -0.44 | -28.2051282051 | 1.56 | 2.48 | 0.8 | 3927016 | 1.4848379 | CS |
52 | -0.11 | -8.94308943089 | 1.23 | 2.48 | 0.7801 | 2743913 | 1.40908807 | CS |
156 | -2.29 | -67.1554252199 | 3.41 | 3.6266 | 0.241 | 3774885 | 1.17238362 | CS |
260 | -3.14 | -73.7089201878 | 4.26 | 13.78 | 0.241 | 3573503 | 2.34123228 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions